PCMK
GSK icon

Paragon Capital Management (Kansas)’s GSK GSK Stock Holding History

Paragon Capital Management (Kansas)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50
Closed -$2K – 94
2020
Q1 		$2K Buy
+50
New +$2.67K ﹤0.01% 173
2019
Q3 		– Sell
-800
Closed -$40K – 125
2019
Q2 		$40K Hold
800
– – 0.02% 99
2019
Q1 		$42K Buy
+800
New +$40K 0.02% 96

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Paragon Capital Management (Kansas)'s GSK Position: Q2 2020 in Review

Paragon Capital Management (Kansas) sold out of GSK (GSK) in Q2 2020, closing a stake of 50 shares — an estimated $2K sold.

Paragon Capital Management (Kansas) first reported a position in GSK in Q1 2019 and held it in 3 quarters. The position peaked at $42K in Q1 2019. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • Paragon Capital Management (Kansas) reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
  • Paragon Capital Management (Kansas) sold 50 GSK shares in Q2 2020, an estimated $2K.
  • Paragon Capital Management (Kansas) first reported a position in GSK in Q1 2019 and held it in 3 quarters.
  • Paragon Capital Management (Kansas)'s GSK position peaked at $42K in Q1 2019.
  • 840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Paragon Capital Management (Kansas)'s 13F filing for Q2 2020, filed 3 Aug 2020.